Evidence map›Paper›PMID 29679144›Full record

ReviewClinical research in cardiology : official journal of the German Cardiac Society2018

Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?

D Duerschmied, J Brachmann, H Darius, N Frey, H A Katus, W Rottbauer, A Schäfer, H Thiele, C Bode, Uwe Zeymer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical research in cardiology : official journal of the German Cardiac Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Pooled it
  2. Association between atrial fibrillation and Helicobacter pylori.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Pooled it
  3. Article
  4. Review
  5. Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI.Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Review
  6. Article
  7. Review
  8. Observational
  9. Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

D DuerschmiedCardiology and Angiology I, Faculty of Medicine, Heart Center, University of Freiburg, Freiburg, Germany.
J BrachmannDepartment of Cardiology, Angiology, and Pneumology, Second Medical Clinic, Coburg Hospital, Coburg, Germany.
H DariusDepartment of Cardiology, Vascular Medicine and Intensive Care Medicine, Vivantes Neukoelln Medical Centre, Berlin, Germany.
N FreyDepartment of Cardiology and Angiology, University of Kiel, Kiel, Germany.
H A KatusDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
W RottbauerDepartment of Internal Medicine II, Cardiology, Angiology, Pneumology, University of Ulm, Ulm, Germany.
A SchäferDepartment of Cardiology and Angiology, Hannover Medical School, Hanover, Germany.
H ThieleDepartment of Internal Medicine/Cardiology, Heart Center Leipzig - UniversityHospital, Leipzig, Germany.
C BodeCardiology and Angiology I, Faculty of Medicine, Heart Center, University of Freiburg, Freiburg, Germany.
Uwe ZeymerKlinikum Ludwigshafen and Institut für Herzinfarktforschung, Bremserstrasse 79, 67063, Ludwigshafen/Rhein, Germany. uwe.zeymer@t-online.de.
University of Freiburg · DEChristian-Albrechts-Universität zu Kiel · DEHeidelberg University · DEKlinikum Coburg · DEMedizinische Hochschule Hannover · DEStiftung Institut für Herzinfarktforschung · DEUniversität Ulm · DEUniversity Hospital Leipzig · DEVivantes Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) is increasing. Since these patients have a CHA

Indexed as

Percutaneous Coronary InterventionAdministration, OralAnticoagulantsAtrial FibrillationClopidogrelDrug Administration ScheduleEvidence-Based MedicineFibrinolytic AgentsHemorrhageHumansPlatelet Aggregation InhibitorsPractice Guidelines as TopicPractice Patterns, Physicians'Randomized Controlled Trials as TopicRisk AssessmentRisk FactorsAnticoagulantsClopidogrelFibrinolytic AgentsPlatelet Aggregation InhibitorsTiclopidineAtrial fibrillationBleedingsOral anticoagulationPercutaneous coronary intervention

Identifiers

PMID29679144
OpenAlexW2799922239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.